US Bancorp’s Strata Critical Medical Inc SRTA Stock Holding History

US Bancorp’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-71	Closed	-$297	–	4180
2026 Q1	$297	Sell	71 -131	-65%	-$631	﹤0.01%	4059
2025 Q4	$972	Buy	+202	New	+$977	﹤0.01%	3857

Other funds holding SRTA

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $366M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

US Bancorp's SRTA Position: Q2 2026 in Review

US Bancorp sold out of Strata Critical Medical Inc (SRTA) in Q2 2026, closing a stake of 71 shares — an estimated $297 sold.

US Bancorp first reported a position in SRTA in Q4 2025 and held it in 2 quarters. The position peaked at $972 in Q4 2025. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

US Bancorp reported no remaining Strata Critical Medical Inc position as of Q2 2026 after selling out during the quarter.
US Bancorp sold 71 Strata Critical Medical Inc shares in Q2 2026, an estimated $297.
US Bancorp first reported a position in Strata Critical Medical Inc in Q4 2025 and held it in 2 quarters.
US Bancorp's Strata Critical Medical Inc position peaked at $972 in Q4 2025.
139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.